| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 12/11/2002 | CN1384881A Compositions and methods for non-targeted activation of endogenous genes |
| 12/11/2002 | CN1384758A Mutant human CD80 and copositions for and methods of making and using the same |
| 12/11/2002 | CN1384757A Method for down-regulating GDF-8 activity |
| 12/11/2002 | CN1384707A Preserving hemoglobin blood substitute with transparent overwrap |
| 12/11/2002 | CN1383881A Gansukang capsule |
| 12/11/2002 | CN1383877A Prescription for treating piles |
| 12/11/2002 | CN1383872A Kidney-invigorating and Yang-strenghtening wine |
| 12/11/2002 | CN1383870A Fatigue-resisting health food |
| 12/11/2002 | CN1383869A Ointment for healing tranumatic injury fast |
| 12/11/2002 | CN1383867A Medicine for treating depression and its prepn |
| 12/11/2002 | CN1383863A Medicine for treating cough and asthma and its prepn |
| 12/11/2002 | CN1383860A Medicine for treating bladder cancer |
| 12/11/2002 | CN1383856A Tumor treating medicine |
| 12/11/2002 | CN1383854A Syphilis treating Chinese medicine |
| 12/11/2002 | CN1383852A Kidney-strengthening and pregnancy assisting granule |
| 12/11/2002 | CN1383849A Burn and scald treating oil |
| 12/11/2002 | CN1383836A Medicine for treating hyperosteogeny in cervical vertebra and lumbar vertebra |
| 12/11/2002 | CN1383834A Beautifying crocodile glue paste |
| 12/11/2002 | CN1383833A 鳄鱼钙 Crocodile calcium |
| 12/11/2002 | CN1383831A Method and device for preparing concentrated thrombocyte |
| 12/11/2002 | CN1095674C Chinese medicinal composition for cerebrovascular disease, rheumatism and rheumatoid disease |
| 12/11/2002 | CN1095672C Traditional Chinese medicine for treating cirrhosis and liver cancer |
| 12/11/2002 | CN1095671C Blood sugar reducing agent containing powder of silkworm as effective ingredient and its making method |
| 12/11/2002 | CA2412227A1 Use of a composition consisting of or with a content of at least a dissimilated milk serum |
| 12/10/2002 | USRE37933 Locally administering to mammalian vascular smooth muscle cells replication defective recombinant adenovirus comprising gene encoding mammalian gax protein, wherein gene is expressed and proliferation of cells is inhibited |
| 12/10/2002 | US6492494 Method of making a fibrin sealant comprising alpha-2-antiplasmin |
| 12/10/2002 | US6492165 Retrovirus isolated from humans |
| 12/10/2002 | US6491956 Food containing active strains for inhibiting infection and treating gastritis, gastric and duodenal ulcers |
| 12/10/2002 | US6491919 Attenuated lipid and surfactant in aqueous solution |
| 12/10/2002 | US6491917 Antibody composition for debulking blood and bone marrow samples from CML patients |
| 12/10/2002 | US6491912 Porcine cardiomyocytes and their use in treatment of insufficient cardiac function |
| 12/10/2002 | US6491910 Preventing of gastrointestinal disorders due to salmonella, campylobacter, escherichia and/or clostridium by injecting vaccines into poultry eggs during incubation |
| 12/10/2002 | US6491909 Blocking antigen expression in genes of the major histocompatibility complex to prevent graft versus host dieases after grafting islets of langerhans; prophylaxis of diabetes mellitus |
| 12/10/2002 | US6491908 Selective elimination of T cells that recognize specific preselected targets |
| 12/10/2002 | US6491907 Genetic engineered chimera particles comprising capsids from adeno-associated virus and genome inverted terminal repeat sequences as vectors for supplying and expressing nucleotide sequence in cells |
| 12/10/2002 | US6491678 Freezer bag |
| 12/10/2002 | CA2232001C Methods and compositions for prevention and treatment of clostridium difficile-associated diseases |
| 12/10/2002 | CA2093431C Ionically cross-linked polymeric microcapsules |
| 12/10/2002 | CA2080182C Nuclear inhibitor i-92 and its use for the production of a medicament |
| 12/10/2002 | CA1341407C Minactivin |
| 12/08/2002 | CA2386262A1 Method for nasal application of a medicinal substance |
| 12/05/2002 | WO2002097070A1 Ex-vivo isolated cd25+cd4+ t cells with immunosuppressive activity and uses thereof |
| 12/05/2002 | WO2002097069A1 Purification of lineage-specific cells and uses therefor |
| 12/05/2002 | WO2002097068A2 Keratinocytes obtained from embryonic stem cells of mammals |
| 12/05/2002 | WO2002097067A1 A method of purification of cells |
| 12/05/2002 | WO2002097066A2 Human vascular progenitor cells |
| 12/05/2002 | WO2002097065A2 Remodeling of somatic nuclei upon addition of pluripotent cell extracts |
| 12/05/2002 | WO2002097063A1 Production of bioavailable folic acid |
| 12/05/2002 | WO2002097044A2 Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 12/05/2002 | WO2002096939A2 Adenovirus protein ix, its domains involved in capsid assembly, transcriptional activity and nuclear reorganization |
| 12/05/2002 | WO2002096471A2 Viral inactivation process using antioxidant |
| 12/05/2002 | WO2002096467A2 Pharmaceutical use for secreted bacterial effector proteins |
| 12/05/2002 | WO2002096456A1 Use of il-18 inhibitors for treating or preventing cns injuries |
| 12/05/2002 | WO2002096449A1 Carbohydrate modifying agent and drinks containing the modifying agent |
| 12/05/2002 | WO2002096447A2 Pharmaceutical preparation containing active ingredients extracted from the plants centella asiatica, mahonia aquifolium and viola tricolor |
| 12/05/2002 | WO2002096444A2 Plumbago europaea constituents for use against psoriasis and hair loss |
| 12/05/2002 | WO2002096440A1 Cow urine therapy and herbal medicinal composition with cow urine and method of manufacturing the same |
| 12/05/2002 | WO2002096439A1 Use of haematopoietic stem cells in the generation of neural stem cells |
| 12/05/2002 | WO2002096349A2 Vaccination against the feline immunodeficiency virus |
| 12/05/2002 | WO2002096263A2 Eb matrix production from fetal tissues and its use for tissue repair |
| 12/05/2002 | WO2002096203A1 Stem cell differentiation |
| 12/05/2002 | WO2002096195A1 Treatment or replacement therapy using transgenic stem cells delivered to the gut |
| 12/05/2002 | WO2002078720A3 Antibiotics from bacteria isolated from amphibian skin |
| 12/05/2002 | WO2002070557A3 Nuclear hormone receptor ligand binding domain |
| 12/05/2002 | WO2002064757A3 Influenza viruses with enhanced transcriptional and replicational capacities |
| 12/05/2002 | WO2002062968A3 Micro-tubular materials and cell constructs |
| 12/05/2002 | WO2002060234A3 Herbal composition for treatment of neuronal injuries and neuronal degeneration, methods to prepare the same and uses thereof |
| 12/05/2002 | WO2002053110A3 Pharmaceutical preparation for douches and/or irrigations of natural or pathological cavities in the human body |
| 12/05/2002 | WO2002019893A3 Improved cardiac function through administration of es cells |
| 12/05/2002 | WO2002016413A3 Cripto tumour polypeptide |
| 12/05/2002 | WO2002006453A3 Regulation of human desc1-like serine protease |
| 12/05/2002 | WO2001032685A9 Gene expression directed by a super-psa promoter |
| 12/05/2002 | US20020183524 Preparations and use of an Ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester |
| 12/05/2002 | US20020183507 Novel human GABA receptor proteins and polynucleotides encoding the same |
| 12/05/2002 | US20020183492 Isolation of biopolymers from human serum albumin; obtain human serum albumin, expose to ion exchange resin, elute and recover biopolymer |
| 12/05/2002 | US20020183281 For therapy and prophylaxis of disorders that are ameliorated by the inhibition of neuronal monoamine uptake in mammals; disorders including erectile dysfunction, affective disorders, obesity, cerebral function disorders, pain |
| 12/05/2002 | US20020183271 Administering to the patient a human MDA-7 polypeptide or a nucleic acid expressing the human MDA-7 polypeptide in eukaryotic cells, whereby the MDA-7 polypeptide inhibits angiogenesis in the patient |
| 12/05/2002 | US20020183267 For use as antibiotics; for therapy of Staphylococcus aureas infection |
| 12/05/2002 | US20020183261 Oral administration of these can stimulate proliferation of osteoblast, inhibit bone resorption and strengthen bone; can be useful for improvement of osteoporosis, bone fracture, bone pain, etc |
| 12/05/2002 | US20020183253 Effecting an increase in the amount of an endostatin in ocular tissues of an individual afflicted with ocular neovascularization to an ocular neovascularization inhibiting effective amount |
| 12/05/2002 | US20020183251 For use as vaccines, and other drugs for the diagnosis and therapy of prostate cancer |
| 12/05/2002 | US20020183250 For use in therapy of sleep disorders |
| 12/05/2002 | US20020182730 Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease |
| 12/05/2002 | US20020182728 Method for transdifferentiation of non pancreatic stem cells to the pancreatic differentiation pathway |
| 12/05/2002 | US20020182727 Activation immune response for use in the treatment of multiple sclerosis, arthritis, autoimmune and infectious diseases; obtain lymphocytes, incubate with inducer, monitor adjustment in disorder |
| 12/05/2002 | US20020182725 New antigen presenting cells, a process for preparing the same and their use as cellular vaccines |
| 12/05/2002 | US20020182723 Generation of genetically engineered viral vectors; obtain cells, infect with genetically engineered vector, propagate and harvest viral vectors |
| 12/05/2002 | US20020182664 Recovering cell components from sample; obtain cells sample, lyse, centrifuge, withdraw fluid, detect cell components |
| 12/05/2002 | US20020182582 Process for preparing agents containing virus-inactivated vitamin K-dependent plasma components as well as protein C and protein S by membrane chromatography |
| 12/05/2002 | US20020182274 Methods for inhibiting cancer growth, reducing infection and promoting general health with a fermented soy extract |
| 12/05/2002 | US20020182272 Methods of treatment of HIV-associated conditions |
| 12/05/2002 | US20020182271 Inhibiting DNA viral and/or RNA viral replication; inhibiting bacterial growth; inhibiting in vitro HIV infections in human T lymphocyte cells and mononuclear phagocytic lineage cells |
| 12/05/2002 | US20020182261 Forming and preserving a bioremodelable, biopolymer scaffold material; used for hernia repair, prolapse treatment; pelvic floor reconstruction; muscle flap reinforcement; lung tissue support; etc. |
| 12/05/2002 | US20020182260 Comprises polar chromatographic fraction of a fat, oil, or wax from a plant, animal, or mineral source |
| 12/05/2002 | US20020182243 Method of producing nutritional products from human milk tissue and compositions thereof |
| 12/05/2002 | US20020182241 Two-dimensional templates fabricated using high-resolution molding processes are bonded to form three-dimensional scaffold structures with closed lumens. |
| 12/05/2002 | US20020182227 Treatment of virus using chelator and antiviral agent |
| 12/05/2002 | US20020182219 Cancer immunotherapy |
| 12/05/2002 | US20020182217 Time release chelators |
| 12/05/2002 | US20020182198 Purified MANF polypeptide (mature astrocyte-derived neurotrophic factor) of given sequence |